TOP HEADLINES

Featured Story

IMS continues cloud deal blitz with 360 Vantage buy

IMS Health has made its third cloud-based acquisition in as many months, snapping up mobile sales and marketing systems provider 360 Vantage. The deal continues IMS' whirlwind push into the cloud that has also seen it snag Appature and Semantelli in the past few months.

Drugmaker UCB taps IBM for digital medicine effort

Belgian biopharma group UCB has partnered with IBM to provide physicians with a predictive tool for use in treating epileptic patients, and the company has worked on expanding its offerings after patents expired on its epilepsy drug Keppra.

InSilico Genomics grabs $1.5M for fledgling bioinformatics biz

The company has raised 1.2 million euros ($1.5 million) to advance its genomics platform, attracting investments from the online payment group Ogone and Foundation Life Sciences Partners, BioInform reported.

Chinese drug giant tackles drug counterfeiting with mobile service

Guilin Pharmaceuticals has advanced a system to combat use of fake antimalarial drugs. The Chinese drugmaker has launched an SMS-based system for patients in Africa to check whether their antimalarial meds are the real thing.

Pfizer-backed analysis finds dearth of patient-reported outcomes in trials

An analysis of online data found that only 7.4% of 650 clinical trials for diabetes treatments included patient-reported outcomes, which are supposed to shed light on patients' experiences on the meds.

MORE NEWS